// App-Quantinova.ai

190 : Effect of metastatic site biopsy on circulating tumor cell (CTC) count in castrate resistant prostate cancer (CRPC) stage.

Researchers

Presenter

  • Manish Kohli

Principal Investigators

  • Brendan P McMenomy

  • Fernando Quevedo

  • Elizabeth A Scheel

  • Thai Huu Ho

  • Alan Haruo Bryce

  • Ricardo Paz-Fumagalli

  • Timothy J. Moynihan

  • Roxana Stefania Dronca

  • Rui Qin

  • Rachel Carlson

  • Michael B Campion

  • Liewei Wang

  • Brian Addis Costello

  • Henry Clement Pitot

  • Minetta C. Liu

  • Thomas D Atwell

  • Winston Tan

Medical Centers

  • Mayo Clinic, Rochester, Rochester, MN

  • Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, Rochester, MNMayo Clinic, Scottsdale, AZ, Scottsdale, AZDepartment of Medical Oncology, Mayo Clinic, Rochester, MN, Rochester, MN

  • Mayo Clinic Jacksonville, Jacksonville, FL.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

  • Urology

Disease

  • Prostate cancer

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved